Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

caregiving

NHS Evidence calls for guidance accreditation

NHS Evidence has issued a call to producers of healthcare guidance to sign up to its accreditation scheme

NHS second in global health service report

The NHS has come second for overall rankings in a report analysing the health services of seven industrialised nations

NHS targets ‘scaled back’ to cut costs

Key UK National Health Service targets are to be 'scaled back' or abolished in a bid to reduce bureaucracy and management costs

Thousands missing out on diabetes tests

Thousands of diabetes patients are missing out on tests to help manage their disease according to the recently published National Diabetes Audit 

NHS Salford holds first Twitter interview

The first ever NHS Twitter interview generated discussion from 58 contributors and contained over 240 tweets

RCGP updates revalidation guide

The UK's Royal College of General Practitioners has published new revalidation guidance for GPs working in special circumstances

Draft NICE guidance rejects Tyverb for NHS

Draft NICE guidance has recommended against the use of GSK's breast cancer drug, Tyverb, outside clinical trials

Lansley pushes for patient-centred care

In his first speech as secretary of state for health, Andrew Lansley presented his vision for putting patients at the centre of UK healthcare

NHS Direct pilot to help treatment decisions

NHS Direct is piloting three online decision aids to help patients facing difficult decisions make informed healthcare choices

- PMLiVE

RCGP launches ‘Healthy Working UK’

The Royal College of General Practitioners has launched 'Healthy Working UK' – a website providing information concerning work and health

NICE recommends AZ’s Iressa for NSCLC

NICE has recommended AstraZeneca's Iressa as a first line treatment for non-small-cell lung cancer

The future for UK healthcare

A health bill that aims to create an NHS led by clinical decision makers will go before parliament in the next 18 months

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links